HCPLive Network

Flu Vaccine Approved

The FDA announced last week that it had approved the formulation of the 2011-2012 influenza vaccine for the six manufacturers that are licensed to produce and distribute it in the US.
 
Each year, the vaccine contains the three virus strains determined to be those likely to cause the most illness during the upcoming flu season. This year’s vaccine includes the same three strains as last year’s, though those who received the vaccine last year should not be tempted to skip this year’s.
 
“It is important to get vaccinated every year, even if the strains in the vaccine do not change, because the protection received the previous year will diminish over time and may be too low to provide protection into the next year,” said Karen Midthun, MD, director of FDA’s Center for Biologics Evaluation and Research, in a press release.
 
The brand names and manufacturers of vaccine for the upcoming flu season are: Afluria (CSL Limited); Fluarix (GlaxoSmithKline Biologicals); FluLaval (ID Biomedical Corporation); FluMist (MedImmune Vaccines Inc.); Fluvirin (Novartis Vaccines and Diagnostics Limited); and Fluzone, Fluzone High-Dose, and Fluzone Intradermal (Sanofi Pasteur Inc.). (Fluzone Intradermal is delivered via a very small needle into the skin rather than muscle and is available for those aged 18 to 64.)
 
Around the Web
 
FDA approves vaccines for the 2011-2012 influenza season [FDA] 


Further Reading
Monitoring patients’ own intestinal immune responses, researchers at Yale University have identified some of the bacterial culprits driving inflammatory bowel diseases (IBD) such as Crohn’s disease and ulcerative colitis.
A major demonstration project designed to gauge the effectiveness of bundled payments exposed the complications of implementing such a system. Officials say the 3-year study fizzled after participation waned and the number of applicable cases proved too few to be statistically relevant.
New research suggests that oral immunotherapy may trigger anaphylaxis in an unusually high percentage of asthmatic teenagers with high-risk food allergies who failed to adhere to their management plan.
Nine percent of top-selling packaged food products in the United States contain partially hydrogenated oils, with most of these products reporting 0 grams of trans fat per serving, according to a study published Aug. 28 in the U.S. Centers for Disease Control and Prevention's Preventing Chronic Disease.
A 3-year study of a product meant to help patients dealing with a wide range of conditions including diabetes, hypertension, and weight loss showed positive results according to manufacturer EnteroMedics, Inc.
As national and international health agencies and other groups shift their focus during the current outbreak of the Ebola virus from treatment of those patients with the virus to preventing further large scale events, a team of researchers has reported some success in looking at how Ebola compromises an infected person’s immune system.
Attention-deficit/hyperactivity disorder stimulant treatment in children is not associated with significant changes in growth, according to a study published online Sept. 1 in Pediatrics.
More Reading